LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice.

Michael V TulliusRichard A BowenPeter S BackSaša Masleša-GalićSusana NavaMarcus A Horwitz

Published in: mBio (2024)

; this vector platform has previously been used successfully to develop potent vaccines against other Tier 1 select agent diseases including tularemia, anthrax, and plague.

Keyphrases

high fat diet induced
high throughput
fluorescent probe
anti inflammatory
molecularly imprinted
insulin resistance
high resolution
single cell